The FDA's abrupt decision on Wednesday to cancel next month's vaccine advisory committee meeting — where experts recommend the strains for next season’s flu shot — is raising concerns about whether the U.S. will have enough of the vaccine for the next flu season. Drugmakers already face a tight deadline each year to produce enough doses for distribution in the fall.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
